| Literature DB >> 31457266 |
Anderson I S Silva1, Nathalia B D Lima1, Alfredo M Simas1, Simone M C Gonçalves1.
Abstract
We advance the concept that a single efficient antenna ligand substituted in or added to an otherwise weakly luminescent europium complex is enough to significantly boost its luminescence. Our results, on the basis of photophysical measurements on 5 novel europium complexes and 15 known ones, point in the direction that ligand dissimilarity and ligand diversity are all concepts that clearly play a fundamental role in the luminescence of europium complexes. We show that it is important that a symmetry breaker ligand exists in the complex to enhance ligand dissimilarity and ligand diversity, all mainly affecting the nonradiative decay rate by reducing it. Because the presence of at least one antenna ligand is also obviously necessary, the optimal and the most cost-effective situation can be achieved by adding a single coordination symmetry breaker that is also an efficient antenna, such as 1-(2-thenoyl)-3,3,3-trifluoroacetone or 4,4,4-trifluoro-1-phenyl-1,3-butanedione. In such cases the quantum efficiency, η, is decidedly boosted, as can be verified by going from complex [EuCl2(TPPO)4]Cl·3H2O with η = 0% to the novel complex [EuCl2(BTFA)(TPPO)3], where TPPO stands for triphenylphosphine oxide, with η = 62%.Entities:
Year: 2017 PMID: 31457266 PMCID: PMC6644999 DOI: 10.1021/acsomega.7b00647
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Luminescence Data for All 20 Complexes Considereda,b
| class | complex | τ (ms) | τrad (ms) | τnrad (ms) | η (%) | |||
|---|---|---|---|---|---|---|---|---|
| (i) | [EuCl2(TPPO)4]Cl·3H2O[ | ----- | ----- | ----- | ----- | ----- | ----- | ∼0 |
| (ii) | [EuCl2(DBM)(TPPO)3][ | ----- | ----- | ----- | ----- | ----- | ----- | ∼0 |
| [EuCl2(TTA)(TPPO)3][ | 0.465 | 2151 | 0.943 | 1061 | 0.917 | 1090 | 49 | |
| [EuCl2(BTFA)(TPPO)3] | 0.583 | 1715 | 0.941 | 1063 | 1.531 | 652 | 62 | |
| (iii) | [EuCl(DBM)2(TPPO)2] | 0.131 | 7634 | 0.779 | 1283 | 0.157 | 6351 | 17 |
| [EuCl(TTA)2(TPPO)2] | 0.425 | 2352 | 1.229 | 814 | 0.650 | 1539 | 35 | |
| [EuCl(BTFA)2(TPPO)2] | 0.503 | 1987 | 0.876 | 1142 | 1.183 | 845 | 57 | |
| (iv) | [EuCl(DBM)(TTA)(TPPO)2] | 0.393 | 2545 | 1.193 | 838 | 0.586 | 1707 | 33 |
| [EuCl(DBM)(BTFA)(TPPO)2][ | 0.420 | 2380 | 1.241 | 806 | 0.635 | 1574 | 34 | |
| [EuCl(TTA)(BTFA)(TPPO)2][ | 0.423 | 2364 | 1.215 | 823 | 0.649 | 1541 | 35 | |
| (v) | [Eu(DBM)3(TPPO)2][ | ----- | ----- | 2.985 | 335 | ----- | ----- | ∼0 |
| [Eu(TTA)3(TPPO)2][ | 0.350 | 2857 | 1.256 | 796 | 0.485 | 2061 | 28 | |
| [Eu(BTFA)3(TPPO)2][ | 0.367 | 2725 | 1.088 | 919 | 0.554 | 1806 | 34 | |
| (vi) | [Eu(DBM)2(TTA)(TPPO)2][ | 0.415 | 2410 | 0.924 | 1082 | 0.753 | 1328 | 45 |
| [Eu(TTA)2(DBM)(TPPO)2][ | 0.424 | 2359 | 0.951 | 1052 | 0.765 | 1307 | 45 | |
| [Eu(DBM)2(BTFA)(TPPO)2][ | 0.423 | 2364 | 0.985 | 1015 | 0.741 | 1349 | 43 | |
| [Eu(BTFA)2(DBM)(TPPO)2][ | 0.473 | 2114 | 0.884 | 1131 | 1.017 | 983 | 53 | |
| [Eu(TTA)2(BTFA)(TPPO)2][ | 0.435 | 2299 | 0.915 | 1093 | 0.829 | 1206 | 48 | |
| [Eu(BTFA)2(TTA)(TPPO)2][ | 0.458 | 2184 | 0.945 | 1058 | 0.888 | 1126 | 48 | |
| (vii) | [Eu(DBM)(TTA)(BTFA)(TPPO)2][ | 0.434 | 2303 | 0.967 | 1034 | 0.788 | 1269 | 45 |
Lifetimes, τ; total decay rates, Atot; radiative lifetimes, τrad; radiative decay rates, Arad; nonradiative lifetimes, τnrad; nonradiative decay rates, Anrad; and quantum efficiency, η.
A sequence of dashes, -----, indicates that data could not be measured due to very poor luminescence.
Figure 1Fully optimized Sparkle/RM1 geometry and the chemical structure of the complex [Eu(BTFA)3(TPPO)2].
Figure 2Fully optimized Sparkle/RM1 geometry and the chemical structure of the complex [EuCl2(BTFA)(TPPO)3].
Figure 3Fully optimized Sparkle/RM1 geometry and the chemical structure of the complex [EuCl(BTFA)2(TPPO)2].
Figure 4Chemical structures and chemical partition of the radiative decay rates Arad′ per ligand for complexes [EuCl2(BTFA)(TPPO)3], [EuCl(BTFA)2(TPPO)2], and [EuCl(TTA)(BTFA)(TPPO)2].
Values of Arad′ and the Average Values of Their Chemical Partitions Per Type of Liganda
| average | ||||
|---|---|---|---|---|
| complex | Cl– | β-diketonate | average | |
| [EuCl2(TTA)(TPPO)3][ | 974 | 29 | 179 | 246 |
| [EuCl2(BTFA)(TPPO)3] | 981 | 90 | 131 | 224 |
| [EuCl(DBM)2(TPPO)2] | 1160 | 152 | 363 | 141 |
| [EuCl(BTFA)2(TPPO)2] | 1048 | 23 | 445 | 68 |
| [EuCl(TTA)2(TPPO)2] | 807 | 11 | 396 | 2 |
| [EuCl(DBM)(TTA)(TPPO)2] | 775 | 56 | 331 | 29 |
| [EuCl(DBM)(BTFA)(TPPO)2][ | 736 | 73 | 324 | 8 |
| [EuCl(BTFA)(TTA)(TPPO)2][ | 740 | 47 | 263 | 84 |
Ionic (either chloride or β-diketonate) Arad′ionic, or nonionic Arad′nonionic coordinated to europium(III) for each of the eight chloride containing europium(III) complexes.
Effect of a Single Ionic Coordination Symmetry Breaker on Nonradiative and Radiative Decay Rates, Arad and Anrad, of Europium Complexes [Eu(BTFA)3(TPPO)2][13] and [Eu(TTA)3(TPPO)2][13]
| β-diketonate | coordination symmetry breaker | complex | ||
|---|---|---|---|---|
| BTFA | [Eu( | 919 | 1806 | |
| Cl | [Eu | 1142 | 845 | |
| BTFA | [EuCl2( | 1063 | 652 | |
| TTA | [Eu( | 1058 | 1126 | |
| BTFA | [Eu( | 1093 | 1206 | |
| DBM | [Eu( | 1131 | 983 | |
| BTFA | [Eu( | 1015 | 1349 | |
| average | 1084 | 1027 | ||
| TTA | [Eu( | 796 | 2061 | |
| Cl | [Eu | 814 | 1539 | |
| TTA | [EuCl2( | 1061 | 1090 | |
| BTFA | [Eu( | 1093 | 1206 | |
| TTA | [Eu( | 1058 | 1126 | |
| DBM | [Eu( | 1052 | 1307 | |
| TTA | [Eu( | 1082 | 1328 | |
| average | 1027 | 1266 |
Effect of Fully Diversified Ionic Ligand Coordination on Radiative and Nonradiative Decay rates, Anrad and Arad, for the Europium Complexes [Eu(BTFA)3(TPPO)2][13] and [Eu(TTA)3(TPPO)2][13]
| β-diketonate | complex | ||
|---|---|---|---|
| BTFA | [Eu(BTFA)3(TPPO)2][ | 919 | 1806 |
| [EuCl(DBM)(BTFA)(TPPO)2][ | 806 | 1574 | |
| [EuCl(TTA)(BTFA)(TPPO)2][ | 823 | 1541 | |
| [Eu(DBM)(TTA)(BTFA)(TPPO)2][ | 1034 | 1269 | |
| TTA | [Eu(TTA)3(TPPO)2][ | 796 | 2061 |
| [EuCl(DBM)(TTA)(TPPO)2] | 838 | 1707 | |
| [EuCl(TTA)(BTFA)(TPPO)2][ | 823 | 1541 | |
| [Eu(DBM)(TTA)(BTFA)(TPPO)2][ | 1034 | 1269 |
Reagents and Solvents Employed in the Synthesis Procedures
| reagent/solvent | source | purity (%) |
|---|---|---|
| 1,3-diphenylpropane-1,3-dione (DBM) | Alfa Aesar | 99 |
| 4,4,4-trifluoro-1-phenyl-1,3-butanedione (BTFA) | Alfa Aesar | 99 |
| 1-(2-thenoyl)-3,3,3-trifluoroacetone (TTA) | Alfa Aesar | 99 |
| triphenylphosphine oxide (TPPO) | Sigma-Aldrich | 98 |
| ethanol | J.T. Baker | 99.9 (high-performance liquid chromatography (HPLC)) |
| chloroform | J.T. Baker | 99.9 (HPLC) |
Figure 5Structures of the ligands considered in this work: DBM, BTFA, TTA, and TPPO.
Types of Characterization Analyses and Equipment Used
| analyses | equipment |
|---|---|
| matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) | Autoflex 3 Smart Beam Vertical spectrometer |
| elemental analysis | PerkinElmer CHN2400 |
| infrared spectroscopy | Bruker model IFS 66 spectrophotometer |
| 1H NMR spectroscopy | Varian Unity Plus 400 MHz |
| 31P NMR spectroscopy | Varian Unity Plus 400 MHz |
| 19F NMR spectroscopy | Varian Unity Plus 400 MHz |